TAKEDA PHARMACEUTICAL CO LTD (TAK) — Earnings Call Analysis & IR Page

TAKEDA PHARMACEUTICAL CO LTD is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $59.96B market cap.

Most recent earnings call: Q3 FY25 on Jan 29, 2026.

18 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.72

www.takeda.com/investors/overview

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 18 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TAK.

$ curl https://api.spokenalpha.com/v1/companies/TAK

Get an API key API docs

FAQ

Frequently asked about TAK

Where can I find TAKEDA PHARMACEUTICAL CO LTD's (TAK) earnings call transcripts?

Spoken Alpha indexes TAK's earnings call transcripts at https://spokenalpha.com/companies/TAK. Each call links to attributed speakers and parsed analyst Q&A. TAKEDA PHARMACEUTICAL CO LTD's own investor relations page is at https://www.takeda.com/investors/overview/.

When was TAKEDA PHARMACEUTICAL CO LTD's most recent earnings call?

TAKEDA PHARMACEUTICAL CO LTD (TAK) held its most recent earnings call on 2026-01-29, covering fiscal Q3 2025.

What sector is TAK in?

TAKEDA PHARMACEUTICAL CO LTD (TAK) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

Overview